Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening: An Observational Study Examining the Outcomes of CHEST Expert Panel Recommendations.

Autor: Creamer AW; Lungs For Living, UCL Respiratory, University College London, London, England., Horst C; Lungs For Living, UCL Respiratory, University College London, London, England., Dickson JL; Lungs For Living, UCL Respiratory, University College London, London, England., Tisi S; Lungs For Living, UCL Respiratory, University College London, London, England., Hall H; Lungs For Living, UCL Respiratory, University College London, London, England., Verghese P; Lungs For Living, UCL Respiratory, University College London, London, England., Prendecki R; Lungs For Living, UCL Respiratory, University College London, London, England., Bhamani A; Lungs For Living, UCL Respiratory, University College London, London, England., Khaw CR; Lungs For Living, UCL Respiratory, University College London, London, England., McCabe J; Lungs For Living, UCL Respiratory, University College London, London, England., Limani T; University College London Hospitals NHS Foundation Trust, London, England., Gyertson K; University College London Hospitals NHS Foundation Trust, London, England., Hacker AM; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, England., Teague J; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, England., Farrelly L; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, England., Dawadi S; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, England., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, England., Devaraj A; National Heart and Lung Institute, Imperial College, London, England; Royal Brompton Hospital; and Harefield Hospital, Uxbridge, England., Nair A; University College London Hospitals NHS Foundation Trust, London, England., Janes SM; Lungs For Living, UCL Respiratory, University College London, London, England. Electronic address: s.janes@ucl.ac.uk.

Publikováno v: Chest [Chest] 2024 Apr; Vol. 165 (4), pp. 1020-1024. Date of Electronic Publication: 2023 Oct 31.

Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.

Autor: Tisi S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Creamer AW; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Dickson J; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Horst C; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Quaife S; Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Hall H; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Verghese P; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Gyertson K; University College London Hospitals NHS Foundation Trust, London, UK., Bowyer V; University College London Hospitals NHS Foundation Trust, London, UK., Levermore C; University College London Hospitals NHS Foundation Trust, London, UK., Hacker AM; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK., Teague J; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK., Farrelly L; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK., Nair A; University College London Hospitals NHS Foundation Trust, London, UK., Devaraj A; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton and Harefield NHS Trust, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK., Hurst JR; UCL Respiratory, University College London, London, UK., Janes S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK s.janes@ucl.ac.uk.

Publikováno v: BMJ open respiratory research [BMJ Open Respir Res] 2023 Jun; Vol. 10 (1).

Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis.

Autor: Mikolasch TA; CITR, UCL Respiratory, UCL, London, UK.; Interstitial Lung Disease Service, UCLH NHS Trust, London, UK., George PM; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK.; National Heart and Lung Institute, Imperial College London, UK., Sahota J; CITR, UCL Respiratory, UCL, London, UK.; Interstitial Lung Disease Service, UCLH NHS Trust, London, UK., Nancarrow T; College of Medicine & Health, University of Exeter, Exeter, UK.; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Barratt SL; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Academic Respiratory Unit, University of Bristol, Bristol, UK., Woodhead FA; Institute for Lung Health and Leicester Interstitial Lung Disease Service and NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital, Groby Road, Leicester, LE3, UK.; Department of Respiratory Sciences and Leicester Institute of Structural & Chemical Biology University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester, LE1 5HB, UK., Kouranos V; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK.; National Heart and Lung Institute, Imperial College London, UK., Cope VSA; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK., Creamer AW; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Academic Respiratory Unit, University of Bristol, Bristol, UK., Fidan S; Institute for Lung Health and Leicester Interstitial Lung Disease Service and NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital, Groby Road, Leicester, LE3, UK.; Department of Respiratory Sciences and Leicester Institute of Structural & Chemical Biology University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester, LE1 5HB, UK., Ganeshan B; Institute of Nuclear Medicine, UCL and Department of Nuclear Medicine UCLH, UK., Hoy L; Institute of Nuclear Medicine, UCL and Department of Nuclear Medicine UCLH, UK., Mackintosh JA; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK.; The Prince Charles Hospital, Queensland, Australia., Shortman R; Institute of Nuclear Medicine, UCL and Department of Nuclear Medicine UCLH, UK., Duckworth A; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Fallon J; Department of Respiratory Medicine, Somerset Lung Centre, Musgrove Park Hospital, Taunton, UK., Garthwaite H; Interstitial Lung Disease Service, UCLH NHS Trust, London, UK., Heightman M; Interstitial Lung Disease Service, UCLH NHS Trust, London, UK., Adamali HI; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Academic Respiratory Unit, University of Bristol, Bristol, UK., Lines S; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Win T; Lister Hospital, North East Herts Trust, Stevenage UK., Wollerton R; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK.; National Heart and Lung Institute, Imperial College London, UK., Steward M; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, UK.; National Heart and Lung Institute, Imperial College London, UK., Gibbons M; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Groves AM; Institute of Nuclear Medicine, UCL and Department of Nuclear Medicine UCLH, UK., Gooptu B; Institute for Lung Health and Leicester Interstitial Lung Disease Service and NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital, Groby Road, Leicester, LE3, UK.; Department of Respiratory Sciences and Leicester Institute of Structural & Chemical Biology University of Leicester, Henry Wellcome Building, Lancaster Road, Leicester, LE1 5HB, UK., Scotton CJ; College of Medicine & Health, University of Exeter, Exeter, UK.; Academic Department of Respiratory Medicine, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Porter JC; CITR, UCL Respiratory, UCL, London, UK.; Interstitial Lung Disease Service, UCLH NHS Trust, London, UK.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2022 Dec 01; Vol. 55, pp. 101758. Date of Electronic Publication: 2022 Dec 01 (Print Publication: 2023).

Prognostic factors in chronic hypersensitivity pneumonitis.

Autor: Creamer AW; Bristol Interstitial Lung Disease Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK andrew.creamer@nhs.net., Barratt SL; Bristol Interstitial Lung Disease Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Publikováno v: European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2020 May 15; Vol. 29 (156). Date of Electronic Publication: 2020 May 15 (Print Publication: 2020).